AI assistant
Sending…
EQUIFAX INC — Director's Dealing 2020
Feb 25, 2020
30136_dirs_2020-02-25_20a54874-fe97-4066-b063-91281d338e72.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2020-02-21
Reporting Person: Begor Mark W (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-21 | Common Stock | A | 12694.0000 | $0.0000 | Acquired | 76003.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-21 | Stock Option/Right to Buy | $191.4400 | A | 55919.0000 | Acquired | 2026-02-21 | Common Stock (55919.0000) | Direct |
| 2020-02-21 | Stock Option/Right to Buy | $175.4800 | A | 44321.0000 | Acquired | 2026-02-21 | Common Stock (44321.0000) | Direct |
Footnotes
F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/21/2023.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021.
More from EQUIFAX INC
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Interim / Quarterly Report
2026
Apr 21
Registration Form
2026
Apr 21
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 26